SCHEMBL21821817

SCHEMBL21821817

CC1C(=O)C(=CNCCN2CCN(CCO)CC2)C(=O)CC1c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ KDM1A O60341 4/20 0.40
▸ SIGMAR1 Q99720 4/20 0.39
▸ SLC18A3 Q16572 1/20 0.39
▸ HRH3 Q9Y5N1 1/20 0.37
▸ MAPK1 P28482 1/20 0.36
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ CARM1 Q86X55 1/20 0.34
▸ PRMT6 Q96LA8 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ HDAC6 Q9UBN7 1/20 0.34
▸ DRD2 P14416 1/20 0.34
▸ DRD3 P35462 1/20 0.34
▸ HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21821816 1.00 KDM1A (0.40) KDM1ASIGMAR1SLC18A3HRH3MAPK1
SCHEMBL21821651 0.88 KDM1A (0.41) KDM1ASIGMAR1SLC18A3HRH3MAPK1
SCHEMBL21821648 0.88 KDM1A (0.41) KDM1ASIGMAR1SLC18A3HRH3MAPK1
SCHEMBL26530426 0.87 KDM1A (0.39) KDM1ASIGMAR1SLC18A3HRH3MAPK1
SCHEMBL26533490 0.86 MAP1LC3B (0.35) MAPK1KMT2AALDH1A1CARM1PRMT6
SCHEMBL22111708 0.86 KDM1A (0.39) KDM1ASIGMAR1SLC18A3HRH3MAPK1
SCHEMBL21821973 0.85 KDM1A (0.38) KDM1ASIGMAR1SLC18A3HRH3MEN1
SCHEMBL21821692 0.85 KDM1A (0.38) KDM1ASIGMAR1SLC18A3HRH3MAPK1
SCHEMBL21821975 0.85 KDM1A (0.38) KDM1ASIGMAR1SLC18A3HRH3MEN1
SCHEMBL21821689 0.85 KDM1A (0.38) KDM1ASIGMAR1SLC18A3HRH3MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116969904-A Compounds useful as autophagy modulators, methods of preparation and uses thereof 微境生物医药科技(上海)有限公司 2023-10-31 — — CN disclosed
EP-3632903-B1 COMPOUND USED AS AUTOPHAGY REGULATOR, AND PREPARATION METHOD THEREFOR AND USES THEREOF WIGEN BIOMEDICINE TECH SHANGHAI CO LTD (CN) 2023-10-11 — — EP disclosed
CN-111148740-B Compounds useful as autophagy modulators, methods of preparation and uses thereof 微境生物医药科技(上海)有限公司 2023-08-25 — — CN disclosed
US-11319303-B2 Compound used as autophagy regulator, and preparation method therefor and uses thereof Wigen Biomedicine Technology (shanghai) Co., Ltd. (CN) 2022-05-03 — — US disclosed
US-20200190066-A1 COMPOUND USED AS AUTOPHAGY REGULATOR, AND PREPARATION METHOD THEREFOR AND USES THEREOF Wigen Biomedicine Technology (shanghai) Co., Ltd. (CN) 2020-06-18 — — US disclosed
CN-111148740-A Compounds useful as autophagy modulators and methods of making and using the same 微境生物医药科技(上海)有限公司 2020-05-12 — — CN disclosed
EP-3632903-A1 COMPOUND USED AS AUTOPHAGY REGULATOR, AND PREPARATION METHOD THEREFOR AND USES THEREOF Wigen Biomedicine Technology (Shanghai) Co., Ltd. (CN) 2020-04-08 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11319303-B2 Compound used as autophagy regulator, and preparation method therefor and uses thereof ATG7, SQSTM1, BECN1 KDM1A 3424/4885SIGMAR1 3139/4885SLC18A3 2277/4885
US-20200190066-A1 COMPOUND USED AS AUTOPHAGY REGULATOR, AND PREPARATION METHOD THEREFOR AND USES THEREOF ATG7, SQSTM1, BECN1 KDM1A 3424/4885SIGMAR1 3139/4885SLC18A3 2277/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback